Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
526
DELISTED
Everi Holdings
EVRI
| $35.4M | 0.05% |
4,868,878
+2,331,500
| +92% | +$15.1M |
|
527
C.H. Robinson
CHRW
$17.5B
| $35.4M | 0.05% |
515,308
+128,800
| +33% | +$9.13M |
|
|
FDC
528
DELISTED
First Data Corporation
FDC
| $35.4M | 0.05% |
1,944,472
+717,866
| +59% | +$12M |
|
|
LSXMK
529
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $35.3M | 0.05% |
1,112,591
+808,906
| +266% | +$24.2M |
|
530
Ituran Location and Control
ITRN
$1.06B
| $35.3M | 0.05% |
1,128,700
+3,800
| +0.3% | +$120K |
|
531
CF Industries
CF
$17.7B
| $35.1M | 0.04% |
+1,255,650
| New | +$34.6M |
|
532
Quanta Services
PWR
$101B
| $35.1M | 0.04% |
+1,065,499
| New | +$35.5M |
|
533
Conagra Brands
CAG
$7.39B
| $35M | 0.04% |
979,400
+859,600
| +718% | +$33.3M |
|
|
WIFI
534
DELISTED
Boingo Wireless, Inc.
WIFI
| $34.9M | 0.04% |
2,330,200
+389,195
| +20% | +$5.88M |
|
535
DaVita
DVA
$11.4B
| $34.5M | 0.04% |
533,300
-659,600
| -55% | -$43.7M |
|
|
MIC
536
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $34.3M | 0.04% |
437,800
-121,600
| -22% | -$9.6M |
|
|
AVTA
537
DELISTED
Avantax, Inc. Common Stock
AVTA
| $34.2M | 0.04% |
1,615,200
+429,600
| +36% | +$8.5M |
|
538
Camden Property Trust
CPT
$11.1B
| $34.2M | 0.04% |
400,400
+174,000
| +77% | +$14.6M |
|
539
SBA Communications
SBAC
$19.8B
| $34.1M | 0.04% |
+253,149
| New | +$32.9M |
|
540
Children's Place
PLCE
$53.4M
| $34.1M | 0.04% |
333,960
-386,100
| -54% | -$42.4M |
|
541
Dover
DOV
$27.8B
| $34.1M | 0.04% |
526,026
-24,513
| -4% | -$1.6M |
|
|
CNR
542
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $34M | 0.04% |
2,034,400
-105,620
| -5% | -$1.79M |
|
|
CCF
543
DELISTED
Chase Corporation
CCF
| $33.9M | 0.04% |
317,900
+15,300
| +5% | +$1.6M |
|
544
Scotiabank
BNS
$111B
| $33.9M | 0.04% |
563,900
+58,400
| +12% | +$3.35M |
|
545
Spire
SR
$4.9B
| $33.9M | 0.04% |
485,300
+85,600
| +21% | +$5.98M |
|
546
Douglas Emmett
DEI
$1.99B
| $33.8M | 0.04% |
885,000
+647,700
| +273% | +$25M |
|
|
IPHS
547
DELISTED
Innophos Holdings, Inc.
IPHS
| $33.8M | 0.04% |
770,700
+11,679
| +2% | +$524K |
|
548
NETGEAR
NTGR
$647M
| $33.8M | 0.04% |
783,473
-135,103
| -15% | -$6.19M |
|
|
NFBK
549
DELISTED
Northfield Bancorp
NFBK
| $33.7M | 0.04% |
1,964,618
+61,350
| +3% | +$1.07M |
|
550
TechnipFMC
FTI
$30.1B
| $33.7M | 0.04% |
1,664,410
+1,560,922
| +1,508% | +$35.2M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.